Toxin for Tics: Practical Guidance for Clinicians from a Registry-Based Naturalistic Study.
Abstract
[BACKGROUND] Botulinum toxin is a recommended treatment for tics. There is little practical guidance on the use of this treatment.
[OBJECTIVES] Our aim is to describe our experience using botulinum toxin injections for tics in adults. We provide information on tics treated, muscles injected, and dosages used to give practical guidance.
[METHODS] We analyzed data from the Calgary Adult Tic Registry on tic severity, the tics and muscles injected, and dosages. We assessed treatment length, reasons for discontinuation, and concurrent medications.
[RESULTS] Botulinum toxin was the most used medication for tics, received by 32 of 95 (33.7%) registry participants. Participants receiving botulinum toxin were significantly older and had significantly lower vocal tic severity and total tic severity. The most common motor tics treated were blinking, head turns, and shoulder raising. The mean length of treatment was 40.4 months.
[CONCLUSIONS] Botulinum toxin is an effective and well-tolerated treatment for adults with tics.
[OBJECTIVES] Our aim is to describe our experience using botulinum toxin injections for tics in adults. We provide information on tics treated, muscles injected, and dosages used to give practical guidance.
[METHODS] We analyzed data from the Calgary Adult Tic Registry on tic severity, the tics and muscles injected, and dosages. We assessed treatment length, reasons for discontinuation, and concurrent medications.
[RESULTS] Botulinum toxin was the most used medication for tics, received by 32 of 95 (33.7%) registry participants. Participants receiving botulinum toxin were significantly older and had significantly lower vocal tic severity and total tic severity. The most common motor tics treated were blinking, head turns, and shoulder raising. The mean length of treatment was 40.4 months.
[CONCLUSIONS] Botulinum toxin is an effective and well-tolerated treatment for adults with tics.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 | |
| 해부 | muscles
|
scispacy | 1 | ||
| 합병증 | head
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Botulinum toxin
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [RESULTS] Botulinum toxin
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Botulinum toxin
|
scispacy | 1 | ||
| 질환 | tics
|
C0040188
Tic disorder
|
scispacy | 1 | |
| 질환 | tic
|
C0040188
Tic disorder
|
scispacy | 1 | |
| 질환 | lower vocal tic
|
scispacy | 1 | ||
| 기타 | Toxin
|
scispacy | 1 |
MeSH Terms
Humans; Male; Female; Registries; Adult; Middle Aged; Tics; Botulinum Toxins; Young Adult; Neuromuscular Agents; Treatment Outcome; Aged; Botulinum Toxins, Type A; Adolescent
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.